About Us

Tablets packages

Our Goal

We are developing first-in-class, daily tablet protein and peptide replacement therapies, designed for patients to live healthier and injection-free, as they manage their chronic diseases. Our goal is for our small, oral protein tablets to change treatment outcomes for patients globally.

Our lead program is potentially the first oral osteoanabolic (bone forming) daily tablet to treat osteoporosis – a disease that disproportionately affects women and where current bone forming agents are only available in injectable formats.

We aspire to continue to validate our platform across a plethora of additional high value therapeutic proteins via our internal efforts and in collaboration with leading protein therapeutic companies.

Scientific Advisory Board

Professor John P. Bilezikian

Vice-Chair, Department of Medicine for International Research and Education; Chief, Emeritus, of the Division of Endocrinology; Director, Emeritus, of the Metabolic Bone Diseases Program at Columbia University Medical Center

Professor Maria Luisa Brandi

Professor of Endocrinology, FIRMO Foundation, Florence, Italy

Professor Bart Clarke

Professor of Medicine and Consultant, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic

Professor Felicia Cosman

Professor of Medicine, Emerita, Columbia University College of Physicians and Surgeons, Division of Endocrinology; Co-Editor in Chief of the journal Osteoporosis International

Professor William Fraser

Professor of Medicine and Deputy Head of Norwich Medical School at the University of East Anglia and Consultant in Metabolic Medicine at the Norfolk and Norwich University Hospital, UK

Dr. Roger Garceau

Former Chief Medical Officer and EVP at NPS Pharmaceuticals and Shire plc (Natpara®); with previous senior management roles at Sanofi Aventis and Pharmacia

Professor Sophia Ish-Shalom

Vice President of the Israeli Foundation for Osteoporosis and Bone Diseases (IFOB), Endocrine Clinic Elisha Hospital; prior Head of Bone and Mineral Metabolism Unit, Rambam Health Care Campus , Haifa Israel

Professor Socrates Papapoulos

Emeritus Professor in Diseases of Bone & Mineral Metabolism, Advisor Center for Bone Quality, Leiden University Medical Center, The Netherlands